Peter Barrett

Peter Barrett

Chairman at SYNLOGIC, INC.

Net worth: 3 M $ as of 2026-05-30

74 year
Health Technology
Commercial Services
Health Services

Profile

Peter Barrett founded Celera Corp.
in 1998, where he worked as Chief Business Officer & Executive Vice President from 1998 to 2002.
Dr. Barrett also currently works at Cadent Therapeutics, Inc., as Chairman, Synlogic, Inc., as Independent Chairman from 2017, Nucleate Bio, Inc., as Director, and various other companies.
Dr. Barrett also formerly worked at Momenta Pharmaceuticals, Inc., as Chairman from 2003 to 2008, Ivrea Pharmaceuticals, Inc., as Chairman, Zafgen, Inc., as Chairman, and various other companies.
Dr. Barrett received his doctorate degree in 1979 from Northeastern University and undergraduate degree from the University of Massachusetts Lowell.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-06 28,293 ( 0.03% ) 3 M $ 2026-05-30

Peter Barrett active positions

CompaniesPositionStart
SYNLOGIC, INC. Chairman 2017-08-27
REVVITY, INC. Director/Board Member 2012-02-06
Director/Board Member 2022-01-18
Chairman -
Director/Board Member 2019-12-16
Corporate Officer/Principal -
Corporate Officer/Principal -
Private Equity Investor 2001-12-31
Director/Board Member -
░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░

Former positions of Peter Barrett

CompaniesPositionEnd
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Peter Barrett's experience

Training of Peter Barrett

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

40

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies40

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Services

Health Technology

Consumer Services

Analytical Life Science & Diagnostics Association

Consumer Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Nucleate Bio, Inc.

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!